BYSI Projected Dividend Yield
Ord/BeyondSpring Inc ( NASDAQ : BYSI )BeyondSpring Inc. is a clinical-stage global biopharmaceutical company. Co. is focused on developing innovative therapies to improve clinical outcomes for patients with high unmet medical needs. Co. operates through two segments: the Plinabulin pipeline and Targeted Protein Degradation (TPD) platform. Plinabulin is being developed as a pipeline in a drug in various cancer indications as a direct anti-cancer agent and to prevent chemotherapy-induced neutropenia (CIN). Plinabulin is a small molecule derived from a natural compound found in marine microorganisms. It is a selective immunomodulating microtubule-binding agent (SIMBA), which may provide multiple therapeutic opportunities. 20 YEAR PERFORMANCE RESULTS |
BYSI Dividend History Detail BYSI Dividend News BYSI Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |